Research Article
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study
Table 3
Improvements in spontaneously reported symptoms and HRQOL per cohort with voxelotor treatment.
| | Patients reporting improvements, / (%) | Adults and adolescents | Caregivers | Children |
| | Pain crises | (91.3) | (71.4) | (80.0) | | Jaundice | (94.7) | (80.0) | | | Fatigue | (84.2) | (50.0) | (75.0) | | Overall HRQOL | (91.3) | (80.0) | (75.0) | | Everyday activities | (65.2) | — | — | | Social life | (56.5) | — | — | | Work and school | (39.1) | — | — | | Emotional health and well-being | (69.6) | — | — |
|
|
HRQOL: health-related quality of life.
|
